[HTML][HTML] Study on the liver Drug's dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction
Q Wang, T Tang, Z Wu, H Yang, Y Gao… - Frontiers in …, 2023 - frontiersin.org
Objective: To investigate the dominant metabolic enzymes of six effective components
(astragaloside IV, glycyrrhizic acid, calycosin-glucuronide, formononetin, ononin, calycosin …
(astragaloside IV, glycyrrhizic acid, calycosin-glucuronide, formononetin, ononin, calycosin …
Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual‐like protein 1 and acyl …
S Zhu, Z Kang, F Zhang - Journal of Diabetes Investigation, 2024 - Wiley Online Library
Abstract Aims/Introduction Tanshinone IIA (TIIA) is one of the main components of the root of
the red‐rooted Salvia miltiorrhiza Bunge. However, the molecular mechanisms underlying …
the red‐rooted Salvia miltiorrhiza Bunge. However, the molecular mechanisms underlying …
Risk factors for macro vascular disease in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease.
Y Zhang, L Wang, X Zheng, H Wang… - Pakistan Journal of …, 2023 - search.ebscohost.com
This study investigates the connection between abnormal liver enzymes and macro vascular
disease in type 2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease …
disease in type 2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease …
[HTML][HTML] Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathy
J Ling, YH Yang - World Journal of Diabetes, 2023 - ncbi.nlm.nih.gov
BACKGROUND Early diabetic nephropathy (DN) is a complication of diabetes mellitus. It
mainly affects kidney microvessels and glomerular function, and its timely and effective …
mainly affects kidney microvessels and glomerular function, and its timely and effective …
2 型糖尿病肾病患者中医证型系统聚类分析及与疾病分期的关系.
田永明， 武士锋， 赵晰 - Journal of Practical Medicine …, 2023 - search.ebscohost.com
目的探讨2 型糖尿病肾病(type 2 diabetic nephropathy, T2DN) 患者中医证型系统聚类分析及与
疾病分期之间的关系. 方法选择2020 年3 月至2022 年10 月于天津中医药大学第一附属医院 …
疾病分期之间的关系. 方法选择2020 年3 月至2022 年10 月于天津中医药大学第一附属医院 …
[HTML][HTML] A Network Pharmacology Approach to Understand the Action Mechanisms of the TangShenKangPing Decoction for Diabetic Nephropathy Treatment
J Chang, X Li, J Wang, Y Zhong - Integrative Medicine in …, 2023 - journals.lww.com
Background: TangShenKangPing decoction (TSKPD) has been used to treat patients with
diabetic nephropathy (DN) for more than 10 years. However, its active ingredients and their …
diabetic nephropathy (DN) for more than 10 years. However, its active ingredients and their …
芪地固肾方治疗糖尿病肾病蛋白尿的疗效观察.
周晓宇， 雷根平， 董盛， 王婷 - … & Analysis of Drug-Use in …, 2023 - search.ebscohost.com
摘要目的: 回顾性分析芪地固肾方治疗糖尿病肾病(DN) 蛋白尿的临床效果及安全性. 方法:
选取2019 年1 月至2022 年1 月该院脾肾气虚型DN 患者80 例, 采用计算机随机分组方法分配 …
选取2019 年1 月至2022 年1 月该院脾肾气虚型DN 患者80 例, 采用计算机随机分组方法分配 …
[PDF][PDF] 肾经水肿汤对糖尿病肾病大鼠的保护作用及调节机制
左封， 李晶， 白梦婷， 吴悠， 陈伟栋 - 河北医学, 2024 - hbyxzzs.cn
目的: 探讨肾经水肿汤(Shenjingshuizhong decoction) 对糖尿病肾病(DN)
大鼠的保护作用及调节机制. 方法: 将60 只SPF 级SD 雄性大鼠随机分为正常对照组, DN …
大鼠的保护作用及调节机制. 方法: 将60 只SPF 级SD 雄性大鼠随机分为正常对照组, DN …
[HTML][HTML] 灵芝多糖通过增加Nrf2, 降低IL-1 阻止糖尿病肾病的铁死亡
徐顺娟， 万磊， 张杰涛 - Advances in Clinical Medicine, 2023 - hanspub.org
目的: 铁死亡导致多种急性, 慢性肾损伤, 包括糖尿病肾病(DN), 本研究评估灵芝多糖(GLPs)
在抑制铁死亡, 保护糖尿病诱导肾小管损伤的作用和机制. 方法: 调取GEO 数据库数据 …
在抑制铁死亡, 保护糖尿病诱导肾小管损伤的作用和机制. 方法: 调取GEO 数据库数据 …
Clinical study on prescription used for invigorating spleen, reinforcing kidney and warming yang combined with calcium dobesilate in treatment of senile diabetic …
L Zhu, J Zhao, Q Li - Biotechnology and Genetic Engineering …, 2023 - Taylor & Francis
Objective. To analyze the clinical effect of prescription used for invigorating spleen,
reinforcing kidney and warming yang combined with calcium dobesilate to treat senile …
reinforcing kidney and warming yang combined with calcium dobesilate to treat senile …